 |
PDBsum entry 4zhr
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class 1:
|
 |
Chains A, B:
E.C.2.7.7.-
- ?????
|
|
 |
 |
 |
 |
 |
Enzyme class 2:
|
 |
Chains A, B:
E.C.2.7.7.49
- RNA-directed Dna polymerase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
DNA(n) + a 2'-deoxyribonucleoside 5'-triphosphate = DNA(n+1) + diphosphate
|
 |
 |
 |
 |
 |
DNA(n)
|
+
|
2'-deoxyribonucleoside 5'-triphosphate
|
=
|
DNA(n+1)
|
+
|
diphosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 3:
|
 |
Chains A, B:
E.C.2.7.7.7
- DNA-directed Dna polymerase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
DNA(n) + a 2'-deoxyribonucleoside 5'-triphosphate = DNA(n+1) + diphosphate
|
 |
 |
 |
 |
 |
DNA(n)
|
+
|
2'-deoxyribonucleoside 5'-triphosphate
|
=
|
DNA(n+1)
|
+
|
diphosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 4:
|
 |
Chains A, B:
E.C.3.1.-.-
|
|
 |
 |
 |
 |
 |
Enzyme class 5:
|
 |
Chains A, B:
E.C.3.1.13.2
- exoribonuclease H.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Exonucleolytic cleavage to 5'-phosphomonoester oligonucleotides in both 5'- to 3'- and 3'- to 5'-directions.
|
 |
 |
 |
 |
 |
Enzyme class 6:
|
 |
Chains A, B:
E.C.3.1.26.13
- retroviral ribonuclease H.
|
|
 |
 |
 |
 |
 |
Enzyme class 7:
|
 |
Chains A, B:
E.C.3.4.23.16
- HIV-1 retropepsin.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Specific for a P1 residue that is hydrophobic, and P1' variable, but often Pro.
|
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Acta Crystallogr F Struct Biol Commun
71:1384-1390
(2015)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure of the HIV-1 reverse transcriptase Q151M mutant: insights into the inhibitor resistance of HIV-1 reverse transcriptase and the structure of the nucleotide-binding pocket of Hepatitis B virus polymerase.
|
|
A.Nakamura,
N.Tamura,
Y.Yasutake.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Hepatitis B virus polymerase (HBV Pol) is an important target for anti-HBV drug
development; however, its low solubility and stability in vitro has hindered
detailed structural studies. Certain nucleotide reverse transcriptase (RT)
inhibitors (NRTIs) such as tenofovir and lamivudine can inhibit both HBV Pol and
Human immunodeficiency virus 1 (HIV-1) RT, leading to speculation on structural
and mechanistic analogies between the deoxynucleotide triphosphate
(dNTP)-binding sites of these enzymes. The Q151M mutation in HIV-1 RT, located
at the dNTP-binding site, confers resistance to various NRTIs, while maintaining
sensitivity to tenofovir and lamivudine. The residue corresponding to Gln151 is
strictly conserved as a methionine in HBV Pol. Therefore, the structure of the
dNTP-binding pocket of the HIV-1 RT Q151M mutant may reflect that of HBV Pol.
Here, the crystal structure of HIV-1 RT Q151M, determined at 2.6 Å
resolution, in a new crystal form with space group P321 is presented. Although
the structure of HIV-1 RT Q151M superimposes well onto that of HIV-1 RT in a
closed conformation, a slight movement of the β-strands (β2-β3) that
partially create the dNTP-binding pocket was observed. This movement might be
caused by the introduction of the bulky thioether group of Met151. The structure
also highlighted the possibility that the hydrogen-bonding network among amino
acids and NRTIs is rearranged by the Q151M mutation, leading to a difference in
the affinity of NRTIs for HIV-1 RT and HBV Pol.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |
|